Impax Laboratories, Inc., a specialty pharmaceutical company, announced it has received final U.S. FDA approval on its ANDA for a...
Read moreArrakis Therapeutics, a pioneering biopharmaceutical company announced that it has released SHAPEware™ as open-source software for the research community with...
Read moreBrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it has...
Read moreEpic Sciences along with researchers at the MD Anderson Cancer Center (MDA) have recently published their findings on androgen receptor...
Read moreIrvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today...
Read morePiramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organisation (CDMO) and part of Piramal Enterprises Ltd. (PEL), announced investments of...
Read moreIn recent years, interest in oligonucleotide therapeutics has resurged, as new approaches, clinical applications, advances in delivery, and a deeper...
Read moreThe 2017 Nobel Prize in Chemistry recognizes the pioneering work of three scientists, Jacques Dubochet, Joachim Frank and Richard Henderson,...
Read moreNeos Therapeutics, a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug...
Read moreHeptares Therapeutics (“Heptares”), a wholly owned subsidiary of Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565), is delighted that one...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.